biotech

This Cancer Study Is a Gamechanger, and the Stock Practically Doubled
Rubius Therapeutics was one of Monday’s biggest winners after it announced initial data from its ongoing Phase 1/2 clinical trial of RTX-240 in patients with advanced solid tumors.
Chris Lange
1 year ago

Intranasal COVID-19 Vaccine Shows Very Promising Preclinical Results
Altimmune has announced additional preclinical data in regards to its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.
Chris Lange
1 year ago

Novavax Could Have the Next Big COVID-19 Vaccine
Novavax stock jumped to close out the week after the firm announced the final efficacy numbers for its COVID-19 vaccine candidate.
Chris Lange
1 year ago

Amgen, Biogen, Gilead, Merck, Pfizer and More Health Care Earnings Coming This Week
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Chris Lange
1 year ago
Last Updated: 1 year ago

Will Gritstone's COVID-19 Vaccine Be the Best One Yet?
Gritstone pushed higher on Tuesday after the company reported that it was advancing the development of a second-generation vaccine against SARS-CoV-2.
Chris Lange
1 year ago

Is Aclaris Therapeutics a Stock to Buy After Nearly 200% Run-Up and Now This?
Aclaris shares more than doubled to start out the week after the company announced positive results from its mid-stage rheumatoid arthritis study.
Chris Lange
1 year ago
Last Updated: 1 year ago

Is Lexicon Pharma a Stock to Buy After 90% Runup and FDA Nod?
Lexicon Pharma shares jumped on Thursday morning after the company announced that it received regulatory feedback from the FDA regarding its heart failure treatment.
Chris Lange
1 year ago

Why Analysts Lost Confidence in the Arcturus COVID-19 Vaccine
Arcturus Therapeutics shares took a tumble on Tuesday after the company announced update on its COVID-19 vaccine candidate.
Chris Lange
1 year ago

Is Aprea Therapeutics Doomed?
Aprea Therapeutics stock was absolutely crushed to start out the week after the company announced results from its late-stage trial evaluating the safety and efficacy of its treatment for...
Chris Lange
1 year ago

Why This Recently Approved Prostate Cancer Treatment Could Be Huge for Myovant
Myovant shares shot up on Monday after the company announced a new collaboration with Pfizer for its tumor treatment across a couple of indications.
Chris Lange
1 year ago

How Big Is This Setback to Altimmune's COVID-19 Vaccine Candidate?
Altimmune shares dropped on Thursday after the company announced that it had received an update from the FDA regarding its COVID-19 vaccine candidate.
Chris Lange
1 year ago
Last Updated: 1 year ago

Agios Pharma's Big Bet on Anemia
Agios Pharmaceuticals shares jumped on Monday after the company announced that it will be streamlining its portfolio.
Chris Lange
1 year ago

5 Top Biotech Stocks to Buy for 2021 With Massive Upside Potential
A new Stifel research report includes the firm's biotech stock picks for 2021. These five have the biggest upside to the posted price targets and are best suited for patient, aggressive growth...
Lee Jackson
1 year ago
Last Updated: 1 year ago

Goldman Sachs Has 4 Sizzling Biotech Stocks to Buy That Are Under $10
These four sizzling biotech stocks trading under the $10 level could provide investors with some solid upside potential. They are all Buy rated at Goldman Sachs, one of the top firms on Wall Street.
Lee Jackson
1 year ago

Why Gilead Retreated on Rheumatoid Arthritis Treatment
Galapagos was crushed on Wednesday after the firm, in conjunction with Gilead, announced a new commercialization and development agreement for their Rheumatoid Arthritis (RA) treatment.
Chris Lange
1 year ago